1. Home
  2. CRBP vs TII Comparison

CRBP vs TII Comparison

Compare CRBP & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.27

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

TII

Titan Mining Corporation

N/A

Current Price

$2.17

Market Cap

219.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
TII
Founded
2009
2012
Country
United States
Canada
Employees
N/A
167
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.4M
219.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CRBP
TII
Price
$9.27
$2.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$45.50
$6.38
AVG Volume (30 Days)
467.9K
1.1M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,822,272.00
N/A
Revenue This Year
N/A
$4.20
Revenue Next Year
$116.00
$3.46
P/E Ratio
N/A
$25.66
Revenue Growth
97.62
N/A
52 Week Low
$7.12
$1.81
52 Week High
$20.56
$5.65

Technical Indicators

Market Signals
Indicator
CRBP
TII
Relative Strength Index (RSI) 57.06 46.42
Support Level $7.42 $1.99
Resistance Level $9.57 $2.44
Average True Range (ATR) 0.50 0.28
MACD 0.21 0.02
Stochastic Oscillator 87.14 27.01

Price Performance

Historical Comparison
CRBP
TII

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About TII Titan Mining Corporation

Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.

Share on Social Networks: